Pfizer beat third-quarter expectations and raised its 2021 forecast again even as sales of its top product, the COVID-19 vaccine Comirnaty, slipped in the U.S. Soaring international sales of the preventive shots helped pushed total Comirnaty revenue close to $13 billion in the quarter, and the drugmaker said Tuesday that it now expects to book about $36 billion in sales from the vaccine this year
Related posts
-
‘Not forgotten’: Palatine honors three firefighters killed in 1973 blaze
Current and former Palatine firefighters, community members and families of the fallen turned out Sunday to... -
Photos: Masses pray for Pope Francis as he remains in critical condition
According to the Vatican, Pope Francis, 88, was still in critical condition Sunday but “remains alert... -
Polar plungers hit the pool for Special Olympics in Fox Lake
About 150 participants jumped into a frigid pool during Sunday’s Fox Lake Polar Plunge for Special...